Skip to main content
Signal8

McKhann Chas

SEC insider (Form 3/4/5 filer). CIK 0001631746. Director at EXAGEN INC. (XGN) and 2 other issuers. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in VISTA, CA.

Companies McKhann Chas has filed insider reports for

  • EXAGEN INC. (XGN): Director
  • Envoy Medical, Inc. (COCH): Director
  • Silk Road Medical Inc (SILK): Director, Officer, Chief Executive Officer
McKhann Chas profile photo

McKhann Chas

CIK: 0001631746

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

EXAGEN INC. logo
XGN

EXAGEN INC.

Director
Envoy Medical, Inc. logo
COCH

Envoy Medical, Inc.

Director
Silk Road Medical Inc logo
SILK

Silk Road Medical Inc

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • EXAGEN INC. logo
    XGN

    EXAGEN INC.

    Jun 9, 2026
    Award

    Stock Option(right to buy)

    Direct
    37.5K shares-
  • Envoy Medical, Inc. logo
    COCH

    Envoy Medical, Inc.

    Apr 15, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    100K shares-
  • Silk Road Medical Inc logo
    SILK

    Silk Road Medical Inc

    Sep 17, 2024
    Disposition
    Direct
    722.4K shares-
  • Silk Road Medical Inc logo
    SILK

    Silk Road Medical Inc

    Sep 17, 2024
    Award
    Direct
    1.3M shares-
  • Silk Road Medical Inc logo
    SILK

    Silk Road Medical Inc

    Sep 17, 2024
    Disposition
    Direct
    1.3M shares-

1-5 of 5